MedPageToday -- Combined estrogen-progestin hormone therapy (HT) appears to increase death from breast cancer as well as overall breast cancer incidence, according to an update of findings from the Women’s Health Initiative (WHI).
MedPageToday -- Combined estrogen-progestin hormone therapy (HT) appears to increase death from breast cancer as well as overall breast cancer incidence, according to an update of findings from the Women’s Health Initiative (WHI).